Common Contracts
2 similar Transition Services Agreement contracts by Bellerophon Therapeutics LLC
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. TRANSITION SERVICES AGREEMENTTransition Services Agreement • January 13th, 2015 • Bellerophon Therapeutics LLC • Pharmaceutical preparations
THIS TRANSITION SERVICES AGREEMENT (the “Agreement”) is made as of February 9, 2014, by and between Bellerophon Therapeutics LLC, a Delaware limited liability company (“R&DCo”), and Ikaria, Inc., a Delaware corporation (“Ikaria”). In this Agreement, each of R&DCo and Ikaria are sometimes referred to individually as a “Party” and, collectively, as the “Parties.”
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. TRANSITION SERVICES AGREEMENTTransition Services Agreement • May 14th, 2014 • Bellerophon Therapeutics LLC • Pharmaceutical preparations
THIS TRANSITION SERVICES AGREEMENT (the “Agreement”) is made as of February 9, 2014, by and between Bellerophon Therapeutics LLC, a Delaware limited liability company (“R&DCo”), and Ikaria, Inc., a Delaware corporation (“Ikaria”). In this Agreement, each of R&DCo and Ikaria are sometimes referred to individually as a “Party” and, collectively, as the “Parties.”
